Brief: Compugen Reports Q4 Loss Per Share Of $0.04

Compugen

27/02/2023 12:13

Feb 27 (Reuters) - Compugen Ltd  CGEN.TA :
    * COMPUGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS
    * COMPUGEN LTD - ON TRACK TO DOSE FIRST PATIENTS IN MSS CRC
AND
PROC TRIPLE COMBINATION PROOF OF CONCEPT STUDIES IN Q1 2023 AND
Q2 2023, RESPECTIVELY
    * COMPUGEN LTD - INITIAL FINDINGS FROM BOTH TRIPLE
COMBINATION
STUDIES EXPECTED BY END OF 2023
    * COMPUGEN LTD - APPROXIMATELY $83.7 MILLION IN CASH, AS OF
END OF
2022, EXPECTED TO FUND OPERATIONS AT LEAST THROUGH END OF 2024
    * COMPUGEN LTD - QTRLY LOSS PER SHARE $0.04

Source text for Eikon:  ID:nPn3ckmz5a 
Further company coverage:  CGEN.TA 

 ((Reuters.Briefs@thomsonreuters.com;))